Endogenous ADP Ribosylation of High Mobility Group Proteins 1 and 2 and Histone H1 Following DNA Damage in Intact Cells
Overview
Biophysics
Authors
Affiliations
Endogenous ADP ribosylation of nonhistone high-mobility group (HMG) proteins and histone H1 was studied in cultured mouse mammary tumor cells following treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). MNNG treatment of cells caused a rapid and transient increase in ADP ribosylation of histone H1 and HMG 1 and 2, whereas (ADP-ribose)n on HMG 14 and 17 was not affected. 3-Aminobenzamide, an inhibitor of (ADP-ribose)n synthetase, prevented the increase in ADP ribosylation of histone H1 and HMG 1 and 2. This inhibitor enhanced the cell-killing effect of MNNG, but had no significant effect on the removal of methylated purines. The preferential increase in ADP ribosylation of HMG 1 and 2 and histone H1 may be necessary for cell recovery from DNA damage.
Targeting TRPM2 in ROS-Coupled Diseases.
Yamamoto S, Shimizu S Pharmaceuticals (Basel). 2016; 9(3).
PMID: 27618067 PMC: 5039510. DOI: 10.3390/ph9030057.
Xiao P, Liu W Int J Clin Exp Pathol. 2015; 8(9):10800-7.
PMID: 26617792 PMC: 4637607.
Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy.
Yang M, Liu L, Xie M, Sun X, Yu Y, Kang R Autophagy. 2015; 11(2):214-24.
PMID: 25607248 PMC: 4502776. DOI: 10.4161/15548627.2014.994400.
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L Mol Aspects Med. 2014; 40:1-116.
PMID: 25010388 PMC: 4254084. DOI: 10.1016/j.mam.2014.05.001.
Strom C, Helleday T Biomolecules. 2014; 2(4):635-49.
PMID: 24970153 PMC: 4030856. DOI: 10.3390/biom2040635.